Authors:
Park, JK
Koprivica, V
Andrews, DQ
Madike, V
Tayebi, N
Stone, DL
Sidransky, E
Citation: Jk. Park et al., Glucocerebrosidase mutations among African-American patients with type 1 Gaucher disease, AM J MED G, 99(2), 2001, pp. 147-151
Citation: N. Tayebi et al., Gene rearrangement on 1q21 introducing a duplication of the glucocerebrosidase pseudogene and a metaxin fusion gene, HUM GENET, 107(4), 2000, pp. 400-403
Authors:
Koprivica, V
Stone, DL
Park, JK
Callahan, M
Frisch, A
Cohen, IJ
Tayebi, N
Sidransky, E
Citation: V. Koprivica et al., Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease, AM J HU GEN, 66(6), 2000, pp. 1777-1786
Authors:
Castellanos, FX
Lau, E
Tayebi, N
Lee, P
Long, RE
Giedd, JN
Sharp, WS
Marsh, WL
Walter, JM
Hamburger, SD
Ginns, EI
Rapoport, JL
Sidransky, E
Citation: Fx. Castellanos et al., Sampling and analytic considerations in molecular genetics studies of ADHD. The advantages of predicting phenotype from genotype in ADHD research - Castellanos replies, MOL PSYCHI, 4(5), 1999, pp. 414-414
Authors:
Stone, DL
van Diggelen, OP
de Klerk, JBC
Gaillard, JLJ
Niermeijer, MF
Willemsen, R
Tayebi, N
Sidransky, E
Citation: Dl. Stone et al., Is the perinatal lethal form of Gaucher disease more common than classic type 2 Gaucher disease?, EUR J HUM G, 7(4), 1999, pp. 505-509
Authors:
Lau, EK
Tayebi, N
Ingraham, LJ
Winfield, SL
Koprivica, V
Stone, DL
Zimran, A
Ginns, EI
Sidransky, E
Citation: Ek. Lau et al., Two novel polymorphic sequences in the glucocerebrosidase gene region enhance mutational screening and founder effect studies of patients with Gaucher disease, HUM GENET, 104(4), 1999, pp. 293-300